Zenith Epigenetics
  • About
  • Science & Epigenetics
  • Programs
  • Newsroom
  • Contact
  • Connect
    Email
    info@zenithepigenetics.com
    Call
    1 (587) 390-7865
    Share
  • FAQ
Newsroom
  • News Releases
  • Presentations & Events
  • SEDAR Filings

News Releases

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Zenith Epigenetics Update
October 14, 2014
Zenith Epigenetics Strengthens its Management Team with Key Appointments
September 8, 2014
Zenith Epigenetics Closes $4.6 million Private Placement
July 23, 2014
Zenith Epigenetics Appoints Julie Cherrington as President and CEO
July 23, 2014
Zenith Epigenetics Closes $8 million Private Placement
March 14, 2014
Zenith Epigenetics Board Update & Webcast Announcement
February 11, 2014

About

  • Overview
  • Management
  • Board of Directors

Science & Epigenetics

  • What is Epigenetics?
  • BET Inhibitors & Oncology
    • Resistance & Combo Therapy
  • BET Inhibitor Platform
    • Covalent BET Inhibitors
    • Translational Medicine
  • Publications & Posters

Programs

  • Oncology Pipeline
    • Prostate Cancer
    • Breast Cancer
    • Ovarian Cancer
    • Lung Cancer
    • Other Solid Tumor Cancers
  • Partnerships & Collaborations

Newsroom

  • News Releases
  • Presentations & Events
  • SEDAR Filings

Contact

  • Contact
  • Careers
  • Shareholder FAQ

© 2025 zenithepigenetics | Legal | Privacy

Bookmark and Share